Investing
Top Analyst Upgrades & Downgrades (AFL, ALKS, AMLN, GD, GNW, HGSI, IPI, MGM, SNDK, SHAW, VRTX)
February 8, 2011 8:20 am
Last Updated: April 28, 2020 8:15 am
These are some of this Tuesday’s top analyst calls with upgrades, downgrades, and initiations seen from Wall Street research firms.
AFLAC Inc. (NYSE: AFL) Cut to Hold at Citigroup.
Alkermes, Inc. (NASDAQ: ALKS) Started as Neutral at Goldman Sachs.
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) Started as Sell at Goldman Sachs.
General Dynamics Corporation (NYSE: GD) Raised to Buy at Argus.
Genworth Financial Inc. (NYSE: GNW) Cut to Underperform at BofA/ML.
Human Genome Sciences, Inc. (NASDAQ: HGSI) Started as Neutral at Goldman Sachs.
Intrepid Potash, Inc. (NYSE: IPI) Raised to Neutral at BofA/ML.
MGM Resorts International (NYSE: MGM) Raised to Buy at BofA/ML.
SanDisk Corporation (NASDAQ: SNDK) Raised to Buy at Sterne Agee.
The Shaw Group Inc. (NYSE: SHAW) Raised to Buy at UBS.
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) Started as Buy at Goldman Sachs.
You can join our free daily email distribution list to hear more about analyst upgrades and downgrades, top day trader and active trader alerts, dividend trends, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.
JON C. OGG
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Editors' Picks
